Product Overview
Generic name: Yangzheng Xiaoji Capsule
Chinese Pinyin: YangZhengXiaoJiJiaoNang
Product name: Yiling Yangzheng Xiaoji Capsules 0.39g*36 capsules
Ingredients: Astragalus, Ligustrum lucidum, Ginseng, Zedoary Turmeric, Ganoderma lucidum, Gynostemma, Stir-fried Atractylodes, Scutellaria barbata, Oldenlandia diffusa, Poria cocos, Euonymus vulgaris, Gallus gallus domesticus, snakeberry, Baiying, Yinchen , Xu Changqing.
Functions and indications: invigorating the spleen and kidney, removing blood stasis and detoxification. It is suitable for the adjuvant treatment of primary liver cancer with deficiency of both spleen and kidney and internal resistance of spleen and toxin that is not suitable for surgery. It can be used in combination with intrahepatic arterial perfusion and embolization chemotherapy to help improve the efficacy of interventional chemotherapy. Reduce the toxic effects on white blood cells, liver function and hemoglobin, and improve the quality of life of patients.
Specification: 0.39g*36 tablets
Usage and dosage: Orally, 4 capsules each time, 3 times a day, used simultaneously with intrahepatic artery perfusion plus embolization chemotherapy. The course of treatment is 4 weeks.
Adverse reactions: This product has inhibitory effect on mouse transplanted tumor S180, liver cancer HAC solid tumor, Lewis lung cancer; it has inhibitory effect on human liver cancer SMMC7721 transplanted in nude mice; this product combined with low-dose chemotherapeutics can inhibit mouse sarcoma S180 Shows a certain synergistic effect; has a certain promotion effect on the proliferation of splenic lymphocytes, NK cell activity and IL-2 production in tumor-bearing mice. It has a certain effect on the reduction of white blood cells in mice caused by cyclophosphamide.
Contraindications: It is forbidden for pregnant women, menstrual and breastfeeding women.
Drug interactions: Drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
Pharmacology and Toxicology: This product has inhibitory effect on mouse transplanted tumor S180, liver cancer HAC solid tumor, Lewis lung cancer; it has inhibitory effect on human liver cancer SMMC7721 transplanted in nude mice; this product is combined with low-dose chemotherapeutics on mouse sarcoma S180 shows a certain synergistic effect; it can promote the proliferation of splenic lymphocytes, NK cell activity and IL-2 production in tumor-bearing mice. It has a certain effect on the reduction of white blood cells in mice caused by cyclophosphamide.
Storage: sealed.
Packing: Aluminum-plastic board.
Validity period: 30 months
Approval number: National Medicine Standard Z20040095
Company Name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
